Nephrology
Microhematuria: AUA/SUFU Guideline
2 Jul, 2020 | 08:38h | UTCMicrohematuria: AUA/SUFU Guideline – American Urological Association
Guideline Summary: Major Consensus Statement on IV Contrast Nephropathy
1 Jul, 2020 | 07:33h | UTCMajor Consensus Statement on IV Contrast Nephropathy – Journal Feed
Original Guideline: ACR/NKF Consensus Statement: “The Risk of Acute Kidney Injury Developing in Patients with Reduced Kidney Function Following Exposure to Intravenous Iodinated Contrast Media has Been Overstated” (Guideline and commentaries)
[Abstract Only] Randomized Trial: Serum Urate Lowering with Allopurinol Does Not Improve Kidney Function in Type 1 Diabetes
26 Jun, 2020 | 09:03h | UTCCommentaries: Despite Lowering Serum Urate Levels, Allopurinol Does Not Slow Kidney Decline in Type 1 Diabete – Physician`s Weekly AND Does Lowering Uric Acid With Allopurinol Slow Progression Of Chronic Kidney Disease? – MedicalResearch.com AND Study finds promising treatment to slow kidney disease doesn’t prove out in clinical trial – University of Minnesota Medical School
AHA/AMA Joint Policy Statement: Self-Measured Blood Pressure Monitoring at Home
23 Jun, 2020 | 08:24h | UTC
Review: Acute Kidney Injury in Critically ill Patients with COVID-19
15 Jun, 2020 | 03:41h | UTCAcute kidney injury in critically ill patients with COVID-19 – Intensive Care Medicine
Characterization of Acute Kidney Injury in Critically Ill Patients with Severe Coronavirus Disease 2019
9 Jun, 2020 | 04:41h | UTCCommentary: Acute kidney disease in critically ill COVID-19 patients – ERA-EDTA
Unruptured Intracranial Aneurysms: Pathogenesis and Individualized Management
1 Jun, 2020 | 03:39h | UTC
[Abstract Only] Study: Primary Aldosteronism Common and Largely Unrecognized in Patients with Hypertension
1 Jun, 2020 | 03:41h | UTCThe Unrecognized Prevalence of Primary Aldosteronism: A Cross-sectional Study – Annals of Internal Medicine (link to abstract – $ for full-text)
A Deep Learning Algorithm to Detect Chronic Kidney Disease from Retinal Photographs
29 May, 2020 | 03:02h | UTC
Related Commentary on Twitter
A deep learning algorithm to detect chronic #KidneyDisease from retinal photographs in community-based populations @LancetDigitalH👉https://t.co/Q4J4LXe9nX pic.twitter.com/J2vA4shtZQ
— The Lancet Reg Health-West Pacific (@LancetRH_WPac) May 20, 2020
Meta-Analysis: ACEI/ARB Use and Risk of Infection or Severity or Mortality of COVID-19
20 May, 2020 | 09:50h | UTCRelated Study (Preprint): Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers with the Risk of Hospitalization and Death in Hypertensive Patients with Coronavirus Disease-19 – medRxiv
Management of Acute Kidney Injury in Patients with COVID-19
19 May, 2020 | 04:40h | UTCManagement of acute kidney injury in patients with COVID-19 – The Lancet Respiratory Medicine
Related: Acute Kidney Injury In Patients Hospitalized With Covid-19 – Kidney International
New NICE Covid-19 Rapid Guidelines: Chronic Kidney Disease & Interstitial Lung Disease
18 May, 2020 | 02:15h | UTCCOVID-19 rapid guideline: chronic kidney disease – National Institute for Health and Care Excellence
See also: Complete Collection of Covid-19 Rapid Guidelines
Meta-Analysis: Furosemide Stress Test as a Predictive Marker of Acute Kidney Injury Progression or Renal Replacement Therapy
11 May, 2020 | 00:12h | UTC
NICE COVID-19 Guideline: Acute Kidney Injury in Hospital
7 May, 2020 | 09:30h | UTC
2020 International Society of Hypertension Global Hypertension Practice Guidelines
7 May, 2020 | 09:00h | UTC2020 International Society of Hypertension Global Hypertension Practice Guidelines – Hypertension
Cohort Study: SLGT2 Inhibitors Linked to Lower Risk of Renal Events in Patients with Type 2 Diabetes
7 May, 2020 | 08:57h | UTCEditorial: SGLT2 inhibitors and kidney outcomes in the real world
Commentary: Certain diabetes drugs may protect against serious kidney problems – The BMJ
Related Analysis: Communicating emerging risks of SGLT2 inhibitors—timeliness and transparency of medicine regulators – The BMJ
New Observational Studies Confirm the Safety of Renin–Angiotensin–Aldosterone System Blockers in Patients with Covid-19
3 May, 2020 | 22:32h | UTCStudy 3: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 – New England Journal of Medicine
Commentary: Blood Pressure Drugs Don’t Increase Coronavirus Risk, Studies Find – The New York Times
See also: Observational Study: Renin-Angiotensin System Inhibitors are Not Associated with Severity or Mortality in Hospitalized Patients with Coronavirus Disease (2 other studies on the subject)
Consensus Statement on Fundamental Concepts in Perioperative Fluid Management
30 Apr, 2020 | 03:51h | UTC
Podcast: Kidney Transplant for the Internist
28 Apr, 2020 | 04:16h | UTC#210 Kidney Transplant for the Internist – The Curbsiders Internal Medicine Podcast
See also: Episode List
[Abstract Only] Meta-Analysis: Delayed vs. Early Initiation of Renal Replacement Therapy for Severe Acute Kidney Injury
26 Apr, 2020 | 21:15h | UTC
Potassium Enriched Salt Substitution Could Prevent a Large Number of Cardiovascular Deaths
23 Apr, 2020 | 09:27h | UTCCommentaries: Salt substitution could prevent almost half a million deaths from CVD in China – George Institute for Global Health AND Embracing salt substitutes could help China prevent 450K CVD deaths per year – Cardiovascular Business
New EULAR Recommendations for the Management of Lupus Nephritis
8 Apr, 2020 | 01:16h | UTCCommentary: EULAR, ERA–EDTA issue guidelines for managing lupus nephritis – Medicine Matters
Related Guidelines: Consensus of the Brazilian Society of Rheumatology for the diagnosis, management and treatment of lupus nephritis (free) AND 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus (free) AND 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus (free) AND Clinical Practice Guidelines for the Treatment of Systemic Lupus Erythematosus by the Mexican College of Rheumatology (free) AND The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults (free) AND First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus (free) AND Canadian Rheumatology Association Recommendations for the Assessment and Monitoring of Systemic Lupus Erythematosus (free PDF)
Related Reviews: Update on Lupus Nephritis – Clinical Journal of the American Society of Nephrology (free) AND Immunosuppressive Treatment for Proliferative Lupus Nephritis – Cochrane Library (free) AND Induction and Maintenance Immunosuppression Treatment of Proliferative Lupus Nephritis: A Network Meta-analysis of Randomized Trials. – American Journal of Kidney Diseases (free)
Study: Saline vs. Lactated Ringer’s Solution in Surgical Patients
7 Apr, 2020 | 04:11h | UTC
COVID-19 and Renin-Angiotensin System Blockers
30 Mar, 2020 | 02:00h | UTCRenin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers – Hypertension AND Commentary: COVID-19 alert: Heart and kidney patients should keep taking their medicines – University of Miami Miller School of Medicine
Related Guidelines: HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19 – American College of Cardiology AND The Renal Association, UK position statement on COVID-19 and ACE Inhibitor/Angiotensin Receptor Blocker use AND Position Statement of the ESC Council on Hypertension on ACE-Inhibitors and Angiotensin Receptor Blockers – European Society of Cardiology
NICE COVID-19 Rapid Guideline: Dialysis Service Delivery
23 Mar, 2020 | 01:30h | UTCSee also: COVID-19: Updates for Nephrologists (free resources)